Thermo Fisher Scientific Inc. TMO
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.64% | 5.82% | 5.13% | 5.82% | 7.09% |
| Total Depreciation and Amortization | 11.17% | 2.05% | -5.64% | -10.55% | -12.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 636.54% | 182.32% | 137.31% | 135.77% | 94.75% |
| Change in Net Operating Assets | 31.79% | 21.81% | -47.00% | -377.04% | -321.47% |
| Cash from Operations | 21.87% | 18.94% | 1.82% | -9.80% | -15.92% |
| Capital Expenditure | -12.21% | -20.38% | -8.76% | -8.93% | -16.23% |
| Sale of Property, Plant, and Equipment | 20.59% | -12.00% | -36.92% | -22.81% | -33.33% |
| Cash Acquisitions | -119.89% | -312.16% | -312.16% | -28.90% | -28.90% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 149.60% | 2,063.25% | 1,237.50% | 207.69% | 134.13% |
| Cash from Investing | -62.32% | -175.07% | -187.71% | 30.71% | 21.15% |
| Total Debt Issued | 168.01% | 309.89% | 310.04% | 635.38% | 6.93% |
| Total Debt Repaid | 11.20% | 29.61% | 8.19% | 2.77% | 3.42% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.87% | -66.67% | -33.33% | 25.00% | -32.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.03% | -8.52% | -8.71% | -9.09% | -9.30% |
| Other Financing Activities | 2,000.00% | 126.42% | -34.62% | -53.61% | -108.00% |
| Cash from Financing | 136.82% | 140.61% | 159.06% | 126.52% | -18.38% |
| Foreign Exchange rate Adjustments | -- | -62.00% | 505.26% | 393.41% | -100.00% |
| Miscellaneous Cash Flow Adjustments | 0.00% | -- | -300.00% | -- | -200.00% |
| Net Change in Cash | 230.99% | 79.67% | 33.78% | 243.92% | -77.50% |